Results 171 to 180 of about 132,304 (290)

Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis. [PDF]

Lancet Reg Health West Pac, 2023
Law M, Ho SSH, Tsang GKC, Ho CMY, Kwan CM, Yan VKC, Yiu HHE, Lai FTT, Wong ICK, Chan EWY.   +9 more
europepmc   +1 more source

Recent Advances in Bioconjugation of Aromatic Amino Acid Residues by a Reactivity‐Guided Approach

The Chemical Record, EarlyView.
This review highlights recent advances in the bioconjugation of aromatic amino acids residues, focusing on strategies that leverage their inherent chemical reactivity to enable precise and versatile modifications of biomacromolecules, illustrating relevant applications.
Bruno M. da S. Santos, Lívia C. R. M. da Frota, Thais G. Silva, Fernanda G. Finelli   +3 more
wiley   +1 more source

Genetic evolution of Akabane virus isolates and the protective efficacy of inactivated vaccines. [PDF]

Virol J
Wang P, Zhang M, Qi Y, Cao X, Ji W, Li X, Liu Z.   +6 more
europepmc   +1 more source

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19. [PDF]

Lancet Microbe, 2021
Lim WW, Mak L, Leung GM, Cowling BJ, Peiris M.   +4 more
europepmc   +1 more source

Impact of general anaesthesia on immune response to first rabies vaccination in seronegative domestic cats

Veterinary Record, EarlyView.
Abstract Background Despite common concerns, evidence that anaesthesia impairs vaccine efficacy remains limited. This study assessed the impact of general anaesthesia on the immune response to rabies vaccination in cats. Methods Thirty‐five healthy female cats (6–12 months old) undergoing elective spaying were enrolled.
Pierre Bessière, Romane Breysse, Marion Chrétien, Brandon Hayes, Séverine Boullier, Anouck Labadie, Jonathan Rieder, Marine Wasniewski, Géraldine Jourdan   +8 more
wiley   +1 more source

Pre-Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS-CoV-2 Inactivated Vaccines. [PDF]

Adv Sci (Weinh)
Ye C, Zhang X, Qiu L, Ji J, Gu J, Jia H, Lu Y, Chen J, Meng Z, Lian J, Yao H, Zeng X, Yang Y.   +12 more
europepmc   +1 more source

Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines. [PDF]

Int J Biol Sci, 2022
Ye ZW, Fan Y, Tang K, Ong CP, Luo C, Chung HL, Leong TL, Liang R, Lui WY, Zhou R, Cheng Y, Lu L, Cheung PH, Chan JF, Chen Z, Yuen KY, Yuan S, To KK, Jin DY.   +18 more
europepmc   +1 more source

Cholera Vaccine Inactivated Oral

Drugs in R & D, 1999
openaire   +2 more sources

Sphinganine‐phosphate prevents influenza infection via promoting CD8+ T cells proliferation and activation

VIEW, EarlyView.
This study established clinical cohorts of respiratory viral infections and identified sphinganine‐phosphate (SA) as a metabolite significantly upregulated post‐infection through metabolomic analysis. In vitro and in vivo experiments demonstrated that SA promotes the generation of effector CD8+ T cells via the SOCS1/JAK1/STAT1 pathway, which ...
Zhongwen Hu, Guiling Yan, Junhong Li, Yuan Yuan, Hong Zhang, Yuchao Zhong, Yuanyuan Peng, Wenjia Zhang, Xiaoyan Su, Changchun Niu, Yang Luo   +10 more
wiley   +1 more source

mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines. [PDF]

NPJ Vaccines
Kaplonek P, Vargas R, Lee JS, Bertera H, Astley E, Girard B, Oostendorp J, Henry C, Paris R, Yu WH, Alter G.   +10 more
europepmc   +1 more source